Published in Transplant Proc on June 01, 2001
Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant (2007) 3.26
Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients. Am J Transplant (2007) 1.77
Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther (1987) 1.62
In situ splitting of cadaveric livers. The ultimate expansion of a limited donor pool. Ann Surg (1996) 1.50
24-hour intragastric acidity and plasma gastrin after omeprazole treatment and after proximal gastric vagotomy in duodenal ulcer patients. Gastroenterology (1990) 1.48
Liver transplantation for metastatic neuroendocrine tumor disease. Transplant Proc (2003) 1.47
Liver transplantation in the Nordic countries, 1982-1998: changes of indications and improving results. Scand J Gastroenterol (1999) 1.45
Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant (2012) 1.42
Twenty-four-hour intragastric acidity and plasma gastrin concentration in healthy subjects and patients with duodenal or gastric ulcer, or pernicious anaemia. Aliment Pharmacol Ther (1987) 1.35
Renal transplantation in the Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. Nephrol Dial Transplant (1991) 1.08
Pseudoaneurysm of the hepatic artery following liver transplantation. Transplant Proc (2006) 1.04
Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation (1995) 1.02
Liver transplantation for polycystic liver disease--indications and outcome. Transplant Proc (2003) 1.02
Liver uptake function measured by IODIDA clearance rate in liver transplant patients and healthy volunteers. Nucl Med Commun (1996) 0.98
Acetazolamide inhibits stimulated feline liver and gallbladder bicarbonate secretion. Acta Physiol Scand (2002) 0.97
Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers. J Hepatol (1998) 0.97
Successful treatment of severe ABO antibody-mediated rejection using bortezomib: a case report. Transplant Proc (2013) 0.97
Liver transplantation for hereditary transthyretin amyloidosis. Liver Transpl (2000) 0.96
A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation. Am J Transplant (2006) 0.95
MELD [corrected] score in patients accepted for liver transplantation 1994 to 2004. Transplant Proc (2006) 0.93
Role of nitric oxide in motility and secretion of the feline hepatobiliary tract. Scand J Gastroenterol (1995) 0.91
Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries. Scand J Gastroenterol (2003) 0.89
Interventional treatment of gastrointestinal neuroendocrine tumours. Digestion (2000) 0.88
Non-suture organ grafting to the neck vessels in rats. Acta Chir Scand (1984) 0.87
Conversion from calcineurin inhibitor to either mycophenolate mofetil or sirolimus improves renal function in liver transplant recipients with chronic kidney disease: results of a prospective randomized trial. Transplant Proc (2010) 0.87
Late mortality in 679 consecutive liver transplant recipients: the Gothenburg liver transplant experience. Transplant Proc (2006) 0.87
Effect of omeprazole on gastric acid secretion and plasma gastrin in man. Scand J Gastroenterol Suppl (1989) 0.87
One-year glomerular filtration rate predicts graft survival in pediatric renal recipients: a randomized trial of tacrolimus vs cyclosporine microemulsion. Transplant Proc (2002) 0.86
Autosomal dominant polycystic kidney disease in a kidney transplant population. Nephrol Dial Transplant (1997) 0.86
Liver transplantation using cavoportal hemitransposition- a life-saving procedure in the presence of extensive portal vein thrombosis. Transplant Proc (2001) 0.86
Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment. Scand J Gastroenterol (1988) 0.86
Monitoring of the intestinal mucosal perfusion using laser Doppler flowmetry after multivisceral transplantation. Transplant Proc (2005) 0.86
Ursodeoxycholic acid for prevention of acute rejection in liver transplant recipients. Lancet (1990) 0.85
Transplantation of preconditioned intestinal grafts is associated with lower inflammatory activation and remote organ injury in rats. Transplant Proc (2006) 0.84
Infectious complications after multivisceral transplantation in adults. Transplant Proc (2006) 0.84
Transplantation in patients with diabetic nephropathy. Outcome of combined pancreas and kidney transplantation compared with kidney transplantation only. Transpl Int (1990) 0.83
Intraluminal polyethylene glycol stabilizes tight junctions and improves intestinal preservation in the rat. Am J Transplant (2012) 0.83
Progeny of survivors of acute lymphocytic leukemia. Acta Paediatr Scand (1979) 0.83
Laparoscopic or open surgery for living donor nephrectomy. Nephrol Dial Transplant (2001) 0.83
Uterus transplantation in a non-human primate: long-term follow-up after autologous transplantation. Hum Reprod (2012) 0.82
Recurrence of SLE in transplanted kidneys: a follow-up transplant biopsy study. Nephrol Dial Transplant (1992) 0.82
Uterine transplantation research: laboratory protocols for clinical application. Mol Hum Reprod (2011) 0.82
Follow-up after liver transplantation for primary sclerosing cholangitis: effects on survival, quality of life, and colitis. Scand J Gastroenterol (1999) 0.81
Mechanisms maintaining transplantation tolerance in antithymocyte globulin-treated rats. Transplantation (1987) 0.81
Retransplantation of the liver. Transplant Proc (2006) 0.81
Preclinical report on allogeneic uterus transplantation in non-human primates. Hum Reprod (2012) 0.80
Morphology of rat cardiac allografts with permanent survival induced by antithymocyte globulin. Scand J Immunol (1988) 0.80
Treatment with the molecular adsorbent recirculating system in patients with acute liver failure. Transplant Proc (2003) 0.80
Spectrum of hereditary renal disease in a kidney transplant population. Nephrol Dial Transplant (1995) 0.80
Induction of long-term heart allograft survival in the rat by rabbit ATG. Int Arch Allergy Appl Immunol (1984) 0.80
Functional and morphological relationships between the feline main pancreatic and bile duct sphincters. Gastroenterology (1990) 0.80
Calculation and comparison of the model for end-stage liver disease (MELD) score in patients accepted for liver transplantation in 1999 and 2004. Transplant Proc (2007) 0.80
Progressive renal impairment in liver transplant recipients on a cyclosporine-based protocol: 5 year follow-up with glomerular filtration rate measurements. Transplant Proc (1997) 0.80
FK506 donor pretreatment improves intestinal graft microcirculation and morphology by concurrent inhibition of early NF-kappaB activation and augmented HSP72 synthesis. Transplant Proc (2005) 0.80
[Control of methicillin resistant staphylococci at the Sahlgrenska hospital. Successful control program against MRSA outbreak]. Lakartidningen (2001) 0.80
Liver transplantation in patients over 60 years of age. Transpl Int (2000) 0.80
Successful ABO-incompatible liver transplantation using A2 donors. Transplant Proc (2006) 0.79
Quality of life after paediatric kidney transplantation: a single-centre experience. Transplant Proc (2001) 0.79
Extended right-sided liver resection for colorectal liver metastases--impact of percutaneous portal venous embolisation. Eur J Surg Oncol (2006) 0.79
Scandiatransplant report 2009. Transplant Proc (2010) 0.79
The liver protective effect of ischemic preconditioning may be mediated by adenosine. Transpl Int (2000) 0.79
Prognostic value of pre-transplant cardiomyopathy in Swedish liver transplanted patients for familial amyloidotic polyneuropathy. Amyloid (2011) 0.79
Liver transplantation in familial amyloidotic polyneuropathy (FAP). A comparative study of transplanted and non-transplanted patient's survival. Transpl Int (1998) 0.79
Aspects of present and future data presentation in Scandiatransplant. Transplant Proc (2009) 0.79
Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab. Transplant Proc (2006) 0.79
Living related liver retransplantation in a 6-month-old child after 60 hours of anhepatic phase following hepatectomy of thrombosed primary liver graft. Transplant Proc (2001) 0.79
Raised pressure in the bile ducts after orthotopic liver transplantation. Transpl Int (1994) 0.79
Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation. Transplant Proc (2005) 0.79
Laser-Doppler flowmetry in the monitoring of the human intestinal allograft: a preliminary report. Transplant Proc (2006) 0.78
New immunosuppressants: testing and development in animal models and the clinic: with special reference to DSG. Immunol Rev (1993) 0.78
Localization of fibrinolytic activators and inhibitors in normal and atherosclerotic vessels. Thromb Haemost (1996) 0.78
Interventional treatment of the carcinoid syndrome. Neuroendocrinology (2004) 0.78
Combined liver and kidney transplantation against a positive cross match in a patient with multispecific HLA-antibodies. Transplant Proc (1997) 0.78
Early outcome of liver transplantation using donors over 60 years of age. Transplant Proc (2001) 0.78
Highly urgent liver transplantation: possible impact of donor-recipient ABO matching on the outcome after transplantation. Transplantation (2003) 0.78
Pharmacological preconditioning of rat liver by up-regulation of heme oxygenase 1. Transplant Proc (2006) 0.78
Single or double arteries in the remnant kidney after donation: influence on the long-term outcome of the donor. Transplant Proc (2009) 0.78
A randomized clinical trial using ATG Fresenius or ATG Merieux as induction therapy in kidney transplantation. Transplant Proc (1997) 0.77